| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:1902176 | BP | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. |
NOL3, VNN1, INS, SOD2, HSPB1, GPX1, AKT1, MAPK7, BAG5 |
GO:1902177 | BP | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. |
SFPQ |
GO:1902186 | BP | regulation of viral release from host cell | Any process that modulates the frequency, rate or extent of viral release from host cell. |
TRIM25, TRIM62 |
GO:1902187 | BP | negative regulation of viral release from host cell | Any process that stops, prevents or reduces the frequency, rate or extent of viral release from host cell. |
TRIM13, TRIM26, TRIM28, TRIM25, TRIM8, TRIM35 |
GO:1902188 | BP | positive regulation of viral release from host cell | Any process that activates or increases the frequency, rate or extent of viral release from host cell. |
CHMP2A, VPS4B, CHMP4B |
GO:1902202 | BP | regulation of hepatocyte growth factor receptor signaling pathway | Any process that modulates the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway. |
PTPN2 |
GO:1902203 | BP | negative regulation of hepatocyte growth factor receptor signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway. |
ADAMTS12 |
GO:1902204 | BP | positive regulation of hepatocyte growth factor receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway. |
ESM1 |
GO:1902206 | BP | negative regulation of interleukin-2-mediated signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-2-mediated signaling pathway. |
PTPN2 |
GO:1902212 | BP | negative regulation of prolactin signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of prolactin signaling pathway. |
PTPN2 |
GO:1902213 | BP | positive regulation of prolactin signaling pathway | Any process that activates or increases the frequency, rate or extent of prolactin signaling pathway. |
CREBRF |
GO:1902215 | BP | negative regulation of interleukin-4-mediated signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-4-mediated signaling pathway. |
PTPN2 |
GO:1902219 | BP | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to osmotic stress. |
ARHGEF2 |
GO:1902227 | BP | negative regulation of macrophage colony-stimulating factor signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of macrophage colony-stimulating factor signaling pathway. |
PTPN2 |
GO:1902230 | BP | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage. |
SNAI2, CLU, TPT1, CXCL12, CCAR2 |
GO:1902231 | BP | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage | Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage. |
SKIL, FBXO18, RAD9A |
GO:1902233 | BP | negative regulation of positive thymic T cell selection | Any process that stops, prevents or reduces the frequency, rate or extent of positive thymic T cell selection. |
PTPN2 |
GO:1902235 | BP | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Any process that modulates the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. |
ERP29 |
GO:1902236 | BP | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. |
PARK2, OPA1, HSPA1A, HSPA1B, XBP1, GRINA, SYVN1, CREB3L1, VIMP |
GO:1902237 | BP | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. |
BCL2L11, PTPN2, DDIT3, SERINC3, PMAIP1 |
GO:1902254 | BP | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway by p53 class mediator. |
PARK2, PTTG1IP, RRN3 |
GO:1902256 | BP | regulation of apoptotic process involved in outflow tract morphogenesis | Any process that modulates the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis. |
TGFB2 |
GO:1902257 | BP | negative regulation of apoptotic process involved in outflow tract morphogenesis | Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis. |
FOXC1 |
GO:1902259 | BP | regulation of delayed rectifier potassium channel activity | Any process that modulates the frequency, rate or extent of delayed rectifier potassium channel activity. |
VAMP2, KCNG1 |
GO:1902260 | BP | negative regulation of delayed rectifier potassium channel activity | Any process that stops, prevents or reduces the frequency, rate or extent of delayed rectifier potassium channel activity. |
ANK3 |
GO:1902261 | BP | positive regulation of delayed rectifier potassium channel activity | Any process that activates or increases the frequency, rate or extent of delayed rectifier potassium channel activity. |
AKAP6 |
GO:1902262 | BP | apoptotic process involved in patterning of blood vessels | Any apoptotic process that is involved in patterning of blood vessels. |
LRP5, BAX |
GO:1902263 | BP | apoptotic process involved in embryonic digit morphogenesis | Any apoptotic process that is involved in embryonic digit morphogenesis. |
BCL2L11, NOTCH1, BAX |
GO:1902268 | BP | negative regulation of polyamine transmembrane transport | Any process that stops, prevents or reduces the frequency, rate or extent of polyamine transmembrane transport. |
OAZ2, OAZ1 |
GO:1902269 | BP | positive regulation of polyamine transmembrane transport | Any process that activates or increases the frequency, rate or extent of polyamine transmembrane transport. |
AZIN1 |
GO:1902275 | BP | regulation of chromatin organization | Any process that modulates the frequency, rate or extent of chromatin organization. |
MKI67 |
GO:1902283 | BP | negative regulation of primary amine oxidase activity | Any process that stops, prevents or reduces the frequency, rate or extent of primary amine oxidase activity. |
PARK2 |
GO:1902285 | BP | semaphorin-plexin signaling pathway involved in neuron projection guidance | Any semaphorin-plexin signaling pathway that is involved in neuron projection guidance. |
NRP1, NRP2, SEMA3A |
GO:1902287 | BP | semaphorin-plexin signaling pathway involved in axon guidance | Any semaphorin-plexin signaling pathway that is involved in axon guidance. |
NRP1, PLXNB2, PLXNC1, PLXNA2, PLXNA3, SEMA3A, PLXNA1, PLXND1 |
GO:1902303 | BP | negative regulation of potassium ion export | Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion export. |
KCNH2 |
GO:1902304 | BP | positive regulation of potassium ion export | Any process that activates or increases the frequency, rate or extent of potassium ion export. |
ANO6 |
GO:1902305 | BP | regulation of sodium ion transmembrane transport | Any process that modulates the frequency, rate or extent of sodium ion transmembrane transport. |
ATP2B4, FGF12, DLG1, SNTA1, RANGRF |
GO:1902306 | BP | negative regulation of sodium ion transmembrane transport | Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transport. |
CAMK2D, COMMD1, NEDD4L |
GO:1902307 | BP | positive regulation of sodium ion transmembrane transport | Any process that activates or increases the frequency, rate or extent of sodium ion transmembrane transport. |
ARF1 |
GO:1902309 | BP | negative regulation of peptidyl-serine dephosphorylation | Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-serine dephosphorylation. |
YWHAE |
GO:1902310 | BP | positive regulation of peptidyl-serine dephosphorylation | Any process that activates or increases the frequency, rate or extent of peptidyl-serine dephosphorylation. |
PPP1R15A, DUSP26 |
GO:1902311 | BP | regulation of copper ion transmembrane transport | Any process that modulates the frequency, rate or extent of copper ion transmembrane transport. |
SLC31A2 |
GO:1902336 | BP | positive regulation of retinal ganglion cell axon guidance | Any process that activates or increases the frequency, rate or extent of retinal ganglion cell axon guidance. |
NRP1, VEGFA |
GO:1902340 | BP | negative regulation of chromosome condensation | Any process that stops, prevents or reduces the frequency, rate or extent of chromosome condensation. |
H3F3A |
GO:1902358 | BP | sulfate transmembrane transport | The directed movement of sulfate across a membrane. |
SLC26A2, SLC26A11, SLC26A1 |
GO:1902378 | BP | VEGF-activated neuropilin signaling pathway involved in axon guidance | Any VEGF-activated neuropilin signaling pathway that is involved in axon guidance. |
NRP1 |
GO:1902380 | BP | positive regulation of endoribonuclease activity | Any process that activates or increases the frequency, rate or extent of endoribonuclease activity. |
HSPA1A, HSPA1B |
GO:1902396 | BP | protein localization to bicellular tight junction | A process in which a protein is transported to, or maintained in, a location within a tight junction. |
ACTN4 |
GO:1902410 | BP | mitotic cytokinetic process | Any cytokinetic process that is involved in mitotic cell cycle. |
CNTROB |
GO:1902414 | BP | protein localization to cell junction | A process in which a protein is transported to, or maintained in, a location within a cell junction. |
MARVELD3 |
GO:1902415 | BP | regulation of mRNA binding | Any process that modulates the frequency, rate or extent of mRNA binding. |
CARM1 |
GO:1902416 | BP | positive regulation of mRNA binding | Any process that activates or increases the frequency, rate or extent of mRNA binding. |
FMR1 |
GO:1902430 | BP | negative regulation of beta-amyloid formation | Any process that stops, prevents or reduces the frequency, rate or extent of beta-amyloid formation. |
APOE, CLU, SORL1 |
GO:1902445 | BP | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death | Any regulation of mitochondrial membrane permeability that is involved in programmed necrotic cell death. |
PPIF, BAX, ALKBH7 |
GO:1902455 | BP | negative regulation of stem cell population maintenance | Any process that stops, prevents or reduces the frequency, rate or extent of stem cell population maintenance. |
ZNF706 |
GO:1902459 | BP | positive regulation of stem cell population maintenance | Any process that activates or increases the frequency, rate or extent of stem cell population maintenance. |
YAP1 |
GO:1902462 | BP | positive regulation of mesenchymal stem cell proliferation | Any process that activates or increases the frequency, rate or extent of mesenchymal stem cell proliferation. |
LTBP3 |
GO:1902463 | BP | protein localization to cell leading edge | A process in which a protein is transported to, or maintained in, a location within a cell leading edge. |
CORO1B |
GO:1902474 | BP | positive regulation of protein localization to synapse | Any process that activates or increases the frequency, rate or extent of protein localization to synapse. |
WNT5A, NLGN1 |
GO:1902475 | BP | L-alpha-amino acid transmembrane transport | The directed movement of L-alpha-amino acid across a membrane. |
SLC7A5, SLC7A6, SLC7A8, SLC7A7 |
GO:1902476 | BP | chloride transmembrane transport | The directed movement of chloride across a membrane. |
FXYD1, CLIC1, BEST1, CLIC3, SLC4A2, CFTR, GABRA5, SLC1A4, GLRB, SLC26A2, CLCN3, CLCN4, CLCN5, CLCN6, CLCN7, CLCNKA, CLCNKB, SLC12A2, CLCA4, ANO6, SLC26A11, BEST3, CLIC6, SLC26A1, TTYH1, ANO2, CLIC5, PCYOX1 |
GO:1902480 | BP | protein localization to mitotic spindle | A process in which a protein is transported to, or maintained in, a location within a mitotic spindle. |
FAM83D |
GO:1902499 | BP | positive regulation of protein autoubiquitination | Any process that activates or increases the frequency, rate or extent of protein autoubiquitination. |
MTA1 |
GO:1902510 | BP | regulation of apoptotic DNA fragmentation | Any process that modulates the frequency, rate or extent of apoptotic DNA fragmentation. |
AIFM1 |
GO:1902511 | BP | negative regulation of apoptotic DNA fragmentation | Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic DNA fragmentation. |
DFFA |
GO:1902512 | BP | positive regulation of apoptotic DNA fragmentation | Any process that activates or increases the frequency, rate or extent of apoptotic DNA fragmentation. |
HSF1, BAX |
GO:1902513 | BP | regulation of organelle transport along microtubule | Any process that modulates the frequency, rate or extent of organelle transport along microtubule. |
LAMP1, NEFH |
GO:1902514 | BP | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | Any process that modulates the frequency, rate or extent of generation of calcium ion transmembrane transport via high voltage-gated calcium channel. |
CAMK2D |
GO:1902523 | BP | positive regulation of protein K63-linked ubiquitination | Any process that activates or increases the frequency, rate or extent of protein K63-linked ubiquitination. |
PTPN22 |
GO:1902524 | BP | positive regulation of protein K48-linked ubiquitination | Any process that activates or increases the frequency, rate or extent of protein K48-linked ubiquitination. |
NMI |
GO:1902525 | BP | regulation of protein monoubiquitination | Any process that modulates the frequency, rate or extent of protein monoubiquitination. |
WDR48 |
GO:1902530 | BP | positive regulation of protein linear polyubiquitination | Any process that activates or increases the frequency, rate or extent of protein linear polyubiquitination. |
PARK2, XIAP |
GO:1902532 | BP | negative regulation of intracellular signal transduction | Any process that stops, prevents or reduces the frequency, rate or extent of intracellular signal transduction. |
LYN, DDIT4 |
GO:1902533 | BP | positive regulation of intracellular signal transduction | Any process that activates or increases the frequency, rate or extent of intracellular signal transduction. |
TNFSF11, TEK, NLGN1, PRKD2 |
GO:1902548 | BP | negative regulation of cellular response to vascular endothelial growth factor stimulus | Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to vascular endothelial growth factor stimulus. |
ADAMTS12 |
GO:1902583 | BP | multi-organism intracellular transport | An intracellular transport which involves another organism. |
RAB7A |
GO:1902598 | BP | creatine transmembrane transport | The directed movement of creatine across a membrane. |
SLC6A8, SLC16A12 |
GO:1902600 | BP | hydrogen ion transmembrane transport | The directed movement of hydrogen ion (proton) across a membrane. |
UQCRHL, NDUFA4, UQCRQ, UQCR11, ATP6V1G1, ATP6V1G2, CYB5A, UQCRH, COX6C, COX6A1, COX6B1, UQCRB, COX7C, COX5A, COX7B, UQCRC1, UQCRFS1, SLC11A2, TMCO3, SLC36A1, COX7B2, SLC9A6, SLC47A1, SLC46A1, NMES1, SLC9A2, UQCR10, COX11 |
GO:1902603 | BP | carnitine transmembrane transport | The directed movement of carnitine across a membrane. |
SLC22A5 |
GO:1902605 | BP | heterotrimeric G-protein complex assembly | The aggregation, arrangement and bonding together of a set of components to form a heterotrimeric G-protein complex. |
PDCL |
GO:1902608 | BP | positive regulation of large conductance calcium-activated potassium channel activity | Any process that activates or increases the frequency, rate or extent of large conductance calcium-activated potassium channel activity. |
GAL |
GO:1902613 | BP | negative regulation of anti-Mullerian hormone signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of anti-Mullerian hormone signaling pathway. |
AMHR2, DKK3 |
GO:1902617 | BP | response to fluoride | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluoride stimulus. |
PON1, FOXO1 |
GO:1902618 | BP | cellular response to fluoride | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluoride stimulus. |
COL1A1 |
GO:1902622 | BP | regulation of neutrophil migration | Any process that modulates the frequency, rate or extent of neutrophil migration. |
RAC2 |
GO:1902626 | BP | assembly of large subunit precursor of preribosome | The aggregation, arrangement and bonding together of a set of components to form the large subunit precursor of the preribosome. |
EIF6, RPL24 |
GO:1902661 | BP | positive regulation of glucose mediated signaling pathway | Any process that activates or increases the frequency, rate or extent of glucose mediated signaling pathway. |
SMARCA4 |
GO:1902679 | BP | negative regulation of RNA biosynthetic process | Any process that stops, prevents or reduces the frequency, rate or extent of RNA biosynthetic process. |
RGN |
GO:1902685 | BP | positive regulation of receptor localization to synapse | Any process that activates or increases the frequency, rate or extent of receptor localization to synapse. |
STX7 |
GO:1902714 | BP | negative regulation of interferon-gamma secretion | Any process that stops, prevents or reduces the frequency, rate or extent of interferon-gamma secretion. |
NR1H4 |
GO:1902715 | BP | positive regulation of interferon-gamma secretion | Any process that activates or increases the frequency, rate or extent of interferon-gamma secretion. |
CD244, PTPN22 |
GO:1902722 | BP | positive regulation of prolactin secretion | Any process that activates or increases the frequency, rate or extent of prolactin secretion. |
EGFR, ABAT |
GO:1902723 | BP | negative regulation of skeletal muscle satellite cell proliferation | Any process that stops, prevents or reduces the frequency, rate or extent of satellite cell proliferation. |
MSTN |
GO:1902725 | BP | negative regulation of satellite cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of satellite cell differentiation. |
MSTN |
GO:1902728 | BP | positive regulation of growth factor dependent skeletal muscle satellite cell proliferation | Any process that activates or increases the frequency, rate or extent of satellite cell proliferation; dependent on specific growth factor activity such as fibroblast growth factors and transforming growth factor beta. |
JAK2, STAT3 |
GO:1902731 | BP | negative regulation of chondrocyte proliferation | Any process that stops, prevents, or reduces the frequency, rate or extent of the multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage. |
BMPR2 |
GO:1902742 | BP | apoptotic process involved in development | Any apoptotic process that is involved in anatomical structure development. |
ZPR1 |
GO:1902745 | BP | positive regulation of lamellipodium organization | Any process that activates or increases the frequency, rate or extent of lamellipodium organization. |
LRRC16A |
GO:1902749 | BP | regulation of cell cycle G2/M phase transition | Any process that modulates the frequency, rate or extent of cell cycle G2/M phase transition. |
TP53, PLK1, NEK10, GTSE1 |
GO:1902750 | BP | negative regulation of cell cycle G2/M phase transition | Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle G2/M phase transition. |
H2AFY |